BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27810567)

  • 1. Development of the EORTC QLQ-CAX24, A Questionnaire for Cancer Patients With Cachexia.
    Wheelwright SJ; Hopkinson JB; Darlington AS; Fitzsimmons DF; Fayers P; Balstad TR; Bredart A; Hammerlid E; Kaasa S; Nicolatou-Galitis O; Pinto M; Schmidt H; Solheim TS; Strasser F; Tomaszewska IM; Johnson CD;
    J Pain Symptom Manage; 2017 Feb; 53(2):232-242. PubMed ID: 27810567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of the European Organisation for Research and Treatment of Cancer quality of life questionnaire module for older people with cancer: The EORTC QLQ-ELD15.
    Johnson C; Fitzsimmons D; Gilbert J; Arrarras JI; Hammerlid E; Bredart A; Ozmen M; Dilektasli E; Coolbrandt A; Kenis C; Young T; Chow E; Venkitaraman R; Howse F; George S; O'Connor S; Yadegarfar G;
    Eur J Cancer; 2010 Aug; 46(12):2242-52. PubMed ID: 20580993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The EORTC QLQ-OH17: a supplementary module to the EORTC QLQ-C30 for assessment of oral health and quality of life in cancer patients.
    Hjermstad MJ; Bergenmar M; Fisher SE; Montel S; Nicolatou-Galitis O; Raber-Durlacher J; Singer S; Verdonck-de Leeuw I; Weis J; Yarom N; Herlofson BB
    Eur J Cancer; 2012 Sep; 48(14):2203-11. PubMed ID: 22572480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I-III development of the EORTC QLQ-ANL27, a health-related quality of life questionnaire for anal cancer.
    Sodergren SC; Johnson CD; Gilbert A; Tomaszewski KA; Chu W; Chung HT; Dennis K; Desideri I; Glynne-Jones R; Grønlie Guren M; Kardamakis D; Nugent K; Schmidt H; Sebag-Montefiore D; Vassiliou V;
    Radiother Oncol; 2018 Feb; 126(2):222-228. PubMed ID: 29217122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of questionnaires for eating-related distress among advanced cancer patients and families.
    Amano K; Morita T; Miura T; Mori N; Tatara R; Kessoku T; Matsuda Y; Tagami K; Otani H; Mori M; Taniyama T; Nakajima N; Nakanishi E; Kako J; Ishiki H; Matsuoka H; Satomi E; Hopkinson JB; Baracos VE; Miyashita M
    J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):310-325. PubMed ID: 36403291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the QLQ-CAX24 instrument in cervical cancer and its association with cachexia classifications.
    Luvián-Morales J; Castillo-Aguilar J; Delgadillo-González M; Cisneros-Sánchez A; Bosch-Gutiérrez J; Castro-Eguiluz D; Cetina-Pérez L; Oñate-Ocaña LF
    Jpn J Clin Oncol; 2023 Mar; 53(4):304-312. PubMed ID: 36579766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EORTC QLQ-COMU26: a questionnaire for the assessment of communication between patients and professionals. Phase III of the module development in ten countries.
    Arraras JI; Wintner LM; Sztankay M; Tomaszewski KA; Hofmeister D; Costantini A; Bredart A; Young T; Kuljanic K; Tomaszewska IM; Kontogianni M; Chie WC; Kulis D; Greimel E;
    Support Care Cancer; 2017 May; 25(5):1485-1494. PubMed ID: 28025709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-cultural development of the EORTC QLQ-SWB36: a stand-alone measure of spiritual wellbeing for palliative care patients with cancer.
    Vivat B; Young T; Efficace F; Sigurđadóttir V; Arraras JI; Åsgeirsdóttir GH; Brédart A; Costantini A; Kobayashi K; Singer S;
    Palliat Med; 2013 May; 27(5):457-69. PubMed ID: 22843128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic criteria of cancer cachexia: relation to quality of life, exercise capacity and survival in unselected palliative care patients.
    Wallengren O; Lundholm K; Bosaeus I
    Support Care Cancer; 2013 Jun; 21(6):1569-77. PubMed ID: 23314651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a disease-specific health-related quality of life questionnaire (THYCA-QoL) for thyroid cancer survivors.
    Husson O; Haak HR; Mols F; Nieuwenhuijzen GA; Nieuwlaat WA; Reemst PH; Huysmans DA; Toorians AW; van de Poll-Franse LV
    Acta Oncol; 2013 Feb; 52(2):447-54. PubMed ID: 23013266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychosocial consequences of cancer cachexia: the development of an item bank.
    Häne H; Oberholzer R; Walker J; Hopkinson JB; de Wolf-Linder S; Strasser F
    J Pain Symptom Manage; 2013 Dec; 46(6):795-806. PubMed ID: 23602324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The validity of EORTC QLQ-C30 fatigue scale in advanced cancer patients and cancer survivors.
    Knobel H; Loge JH; Brenne E; Fayers P; Hjermstad MJ; Kaasa S
    Palliat Med; 2003 Dec; 17(8):664-72. PubMed ID: 14694917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase III development of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire module for women undergoing breast reconstruction.
    Winters ZE; Balta V; Thomson HJ; Brandberg Y; Oberguggenberger A; Sinove Y; Unukovych D; Nava M; Sandelin K; Johansson H; ; Dobbeleir J; Blondeel P; Bruno N; Catanuto G; Llewellyn-Bennett R
    Br J Surg; 2014 Mar; 101(4):371-82. PubMed ID: 24474151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase 1-3 of the cross-cultural development of an EORTC questionnaire for the assessment of sexual health in cancer patients: the EORTC SHQ-22.
    Oberguggenberger AS; Nagele E; Inwald EC; Tomaszewski K; Lanceley A; Nordin A; Creutzberg CL; Kuljanic K; Kardamakis D; Schmalz C; Arraras J; Costantini A; Almont T; Wei-Chu C; Dehandschutter S; Winters Z; Greimel E;
    Cancer Med; 2018 Mar; 7(3):635-645. PubMed ID: 29436144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review to establish health-related quality-of-life domains for intervention targets in cancer cachexia.
    Wheelwright SJ; Darlington AS; Hopkinson JB; Fitzsimmons D; White A; Johnson CD
    BMJ Support Palliat Care; 2016 Sep; 6(3):307-14. PubMed ID: 24943495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of computerised adaptive testing (CAT) for the EORTC QLQ-C30 dimensions - general approach and initial results for physical functioning.
    Petersen MA; Groenvold M; Aaronson NK; Chie WC; Conroy T; Costantini A; Fayers P; Helbostad J; Holzner B; Kaasa S; Singer S; Velikova G; Young T;
    Eur J Cancer; 2010 May; 46(8):1352-8. PubMed ID: 20231085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-cultural development of a quality-of-life measure for patients with melanoma: phase 3 testing of an EORTC Melanoma Module.
    Winstanley JB; Young TE; Boyle FM; Bergenmar M; Bottomley A; Burmeister B; Campana LG; Garioch JJ; King M; Nikolic DV; van de Poll-Franse LV; Saw R; Thompson JF; White EG;
    Melanoma Res; 2015 Feb; 25(1):47-58. PubMed ID: 25325247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life but not cachexia definitions are associated with overall survival in women with cervical cancer: a STROBE-compliant cohort study.
    Luvián-Morales J; Delgadillo-González M; Castro-Eguiluz D; Oñate-Ocaña LF; Cetina-Pérez L
    Jpn J Clin Oncol; 2024 Apr; 54(4):416-423. PubMed ID: 38146122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The EORTC QLQ-HDC29: a supplementary module assessing the quality of life during and after high-dose chemotherapy and stem cell transplantation.
    Velikova G; Weis J; Hjermstad MJ; Kopp M; Morris P; Watson M; Sezer O;
    Eur J Cancer; 2007 Jan; 43(1):87-94. PubMed ID: 17081744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.